Muutke küpsiste eelistusi

Contemporary Issues in Pharmaceutical Patent Law: Setting the Framework and Exploring Policy Options [Pehme köide]

Edited by , Edited by (Chinese University of Hong Kong)
  • Formaat: Paperback / softback, 249 pages, kõrgus x laius: 234x156 mm, kaal: 385 g, 5 Tables, black and white; 5 Illustrations, black and white
  • Sari: Routledge Research in Intellectual Property
  • Ilmumisaeg: 08-Jan-2019
  • Kirjastus: Routledge
  • ISBN-10: 0367193388
  • ISBN-13: 9780367193386
Teised raamatud teemal:
  • Formaat: Paperback / softback, 249 pages, kõrgus x laius: 234x156 mm, kaal: 385 g, 5 Tables, black and white; 5 Illustrations, black and white
  • Sari: Routledge Research in Intellectual Property
  • Ilmumisaeg: 08-Jan-2019
  • Kirjastus: Routledge
  • ISBN-10: 0367193388
  • ISBN-13: 9780367193386
Teised raamatud teemal:

This collection reflects on contemporary and contentious issues in international rulemaking in regards to pharmaceutical patent law. With chapters from both well-established and rising scholars, the collection contributes to the understanding of the regulatory framework governing pharmaceutical patents as an integrated discipline through the assessment of relevant laws, trends and policy options. Focusing on patent law and related pharmaceutical regulations, the collection addresses the pressing issues governments face in an attempt to resolve policy dilemmas involving competing interests, needs and objectives. The common theme running throughout the collection is the need for policy and law makers to think and act in a systemic manner and to be more reflective and responsive in finding new solutions within and outside the patent system to the long-standing problems as well as emerging challenges

Arvustused

'The editors have mustered a wide range of authors, including legal practitioners, academics and a Constitutional Court Justice, to opine on a broad range of topical issues confronting rule-makers concerning pharmaceutical patent law. This diversity makes for a varied discussion.'

John A. Tessensohn, European Intellectual Property Review

'A solid reference book for scholars and those interested in governments struggle between incentivising innovation and access to affordable medicine.'



John A. Tessensohn, European Intellectual Property Review

Notes on Contributors vii
1 Introduction: A Holistic Approach to Pharmaceutical Patent Law and Policy
1(6)
Bryan Mercurio
Daria Kim
PART I Pharmaceutical Patents and Related Types of Protection
7(116)
2 Patentability of Pharmaceutical Inventions under TRIPS: Domestic Court Practice Testing International Policy Space
9(38)
Roberto Romandini
Henning Grosse Ruse-Khan
3 Biologies, Biosimilars and Other Idiosyncrasies
47(21)
Yaniv Heled
4 Index of Data Exclusivity and Access (IDEAS): An Analysis of Test Data Exclusivity Provisions in Free Trade Agreements and National Laws
68(29)
Owais Hassan Shaikh
5 Patent Linkage Regulations: The Importance of Context and of Balancing Competing Interests
97(26)
Bryan Mercurio
PART II Balancing Patent Protection with Available Flexibilities
123(64)
6 The Bolar Exception: Legislative Models and Drafting Options
125(19)
Carlos Correa
7 Compulsory Licensing: Threats, Use and Recent Trends
144(17)
Chang-Fa Lo
8 A Manufacturing for Export Exception
161(26)
Xavier Seuba
Luis Mariano Genovesi
Pedro Roffe
PART III A Broader View on Incentives for Pharmaceutical Innovation
187(54)
9 The Price of Exclusivity: The Economics of Patent Extensions and Data Protection
189(14)
Aidan Hollis
Paul Grootendorst
10 Rationalizing Innovation Incentives under Drug Approval Regulation: National Policy Perspective
203(22)
Daria Kim
11 The Trans-Pacific Partnership Agreement and Its Implications for Access to Medicine
225(16)
Jakkrit Kuanpoth
Index 241
Bryan Mercurio is Professor and Vice Chancellor's Outstanding Fellow of the Faculty of Law at the Chinese University of Hong Kong.



Daria Kim is Doktorandin at the Max Planck Institute for Innovation and Competition.